Human breast cancer cell lines and tissues express tartrate-resistant acid phosphatase (TRAP)

Cell Biology International

Volumn 31, Issue 2, 2007, Pages 191-195

  Adams, Lisa M ^a   Warburton, Michael J ^b   Hayman, Alison R ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Acid phosphatase; Breast cancer; Tartrate resistant

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME;

ARTICLE; BREAST CANCER; BREAST TUMOR; CANCER CELL CULTURE; CANCER TISSUE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; PROTEIN EXPRESSION;

ACID PHOSPHATASE; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; ISOENZYMES;

EID: 33846606299     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2006.09.022     Document Type: Article

References (30)

1. Adams L.M., Warburton M.J., and Hayman A.R. Tartrate-resistant acid phosphatase is expressed by breast cancer cell lines. Eur J Cancer Suppl 2 (2004) 108
2. Angel N.Z., Walsh N., Forwood M.R., Ostrowski M.C., Cassady A.T., and Hume D.A. Transgenic mice overexpressing tartrate-resistant acid phosphatase exhibit an increased rate of bone turnover. J Bone Miner Res 15 (2000) 103-110
3. Bune A.J., Hayman A.R., Evans M.J., and Cox T.M. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus. Immunology 102 (2001) 103-113
4. Burstone M.S. Histochemical demonstration of acid phosphatases with naphthol AS-phosphates. J Natl Cancer Inst 21 (1958) 523-539
5. Capeller B., Caffier H., Sutterlin M.W., and Dietl J. Evaluation of tartrate-resistant acid phosphatase (TRAP) 5b serum marker of bone metastases in human breast cancer. Anticancer Res 23 (2003) 1011-1015
6. Chamberlain P., Compston J., Cox T.M., Hayman A.R., Imrie R.C., Reynolds K., et al. Generation and characterisation of monoclonal antibodies to human type 5 tartrate-resistant acid phosphatase: development of a specific immunoassay of the isozyme in serum. Clin Chem 41 (1995) 1495-1499
7. Ek-Rylander B., Bill P., Norgard M., Nilsson S., and Andersson G. Cloning, sequence and developmental expression of a type 5 tartrate-resistant acid phosphatase of rat bone. J Biol Chem 266 (1991) 24684-24689
8. Esfandiari E., Bailey M., Stokes C.R., Cox T.M., Evans M.J., and Hayman A.R. TRACP influences Th1 pathways by affecting dendritic cell function. J Bone Miner Res 21 (2006) 10.1359/JBMR.060611
9. Halleen J.M. Tartrate-resistant acid phosphatase 5B is a specific and sensitive marker of bone resorption. Anticancer Res 23 (2003) 1027-1029
10. Harris R.A., Hiles I.D., Page M.J., and O'Hare M.J. The induction of apoptosis in human mammary luminal epithelial cells by expression of activated c-neu and its abrogation by glucocorticoids. Br J Cancer 72 (1995) 386-392
11. Hayman A.R., Jones S.J., Boyde A., Foster D., Colledge W.H., Carlton M.B., et al. Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disrupted endochondral ossification and mild osteopetrosis. Development 122 (1996) 3151-3162
12. Hayman A.R., Bune A.J., Bradley J.R., Rashbass J., and Cox T.M. Osteoclastic tartrate-resistant acid phosphatase (Acp 5): its localisation to dendritic cells and diverse murine tissues. J Histochem Cytochem 48 (2000) 219-227
13. Hayman A.R., Bune A.J., and Cox T.M. Widespread expression of tartrate-resistant acid phosphatase (Acp 5) in the mouse embryo. J Anat 196 (2000) 433-441
14. Hayman A.R., Macary P., Lehner P.J., and Cox T.M. Tartrate-resistant acid phosphatase (Acp 5): identification in diverse human tissues and dendritic cells. J Histochem Cytochem 49 (2001) 675-683
15. Hayman A.R., and Cox T.M. Tartrate-resistant acid phosphatase: a potential target for therapeutic gold. Cell Biochem Funct 22 (2004) 275-280
16. Hollberg K., Hultenby K., Hayman A.R., Cox T.M., and Andersson G. Osteoclasts from mice deficient in tartrate-resistant acid phosphatase have altered ruffled borders and disturbed vesicular transport. Exp Cell Res 279 (2002) 227-238
17. Janckila A.J., Nakasato Y.R., Neustadt D.H., and Yam L.T. Disease-specific expression of tartrate-resistant acid phosphatase isoforms. J Bone Miner Res 18 (2003) 1916-1919
18. Janckila A.J., Parthasarathy R.N., Parthasarathy L.K., Seelan R.S., Hsueh Y.C., Rissanen J., et al. Properties and expression of human tartrate-resistant acid phosphatase isoform 5a by monocytes-derived cells. J Leukoc Biol 77 (2005) 209-218
19. Kos J., and Lah T.T. Cysteine proteinases and their endogenous inhibitors: target proteins for prognosis, diagnosis and therapy in cancer. Oncol Rep 5 (1998) 1349-1361
20. Lau K.H., Onishi T., Wergedal J.E., Singer F.R., and Baylink D.J. Characterisation and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 33 (1987) 458-462
21. Ljusberg J., Ek-Rylander B., and Andersson G. Tartrate-resistant purple acid phosphatase is synthesised as a proenzyme and activated by cysteine proteinases. Biochem J 343 (2000) 63-69
22. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34 (1982) 285-290
23. Price J.E. Metastasis from human breast cancer cell lines. Breast Cancer Res Treat 39 (1996) 93-102
24. Reddy S.V., Hundley J.E., Windle J.J., Alacantara O., Linn R., Leach R.I., et al. Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter. J Bone Miner Res 10 (1995) 601-606
25. Sung V., Gilles C., Murray A., Clarke R., Aaron A.D., Azumi N., et al. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype. Exp Cell Res 24 (1998) 273-284
26. Suter A., Everts V., Boyde A., Jones S.J., Lullmann-Rauch R., Hartmann D., et al. Overlapping functions of lysosomal acid phosphatase (LAP) and tartrate-resistant acid phosphatase (Acp 5) revealed by doubly deficient mice. Development 128 (2001) 4899-4910
27. Urquidi V., Sloan D., Kawai K., Agarwal D., Woodman A.C., Tarin D., et al. Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. Clin Cancer Res 8 (2002) 61-74
28. Wada N., Ishii S., Ikeda T., Enomoto K., and Kitajima M. Serum tartrate-resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res 19 (1999) 4515-4521
29. Weber G.F., Ashkar S., and Cantor H. Interaction between CD44 and osteopontin as a potential basis for metastasis formation. Proc Assoc Am Physicians 109 (1997) 1-9
30. Zjac I., Frangez L., and Lah T.T. Expression of cathepsin B is related to tumorigenicity of breast cancer cell lines. Radiol Oncol 37 (2003) 233-240